Edition:
India

Koninklijke DSM NV (DSMN.AS)

DSMN.AS on Amsterdam Stock Exchange

80.42EUR
15 Dec 2017
Change (% chg)

€0.09 (+0.11%)
Prev Close
€80.33
Open
€80.37
Day's High
€80.56
Day's Low
€79.81
Volume
989,691
Avg. Vol
683,122
52-wk High
€81.17
52-wk Low
€55.11

Chart for

About

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company's segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties. Its Performance... (more)

Overall

Beta: 0.83
Market Cap(Mil.): €12,599.97
Shares Outstanding(Mil.): 181.43
Dividend: 0.58
Yield (%): 2.56

Financials

  Industry Sector
P/E (TTM): -- 16.64 16.44
EPS (TTM): -- -- --
ROI: -- 7.32 10.62
ROE: -- 11.68 14.20

BRIEF-DSM acquires Brazilian production facility from Amyris

* DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris

17 Nov 2017

BRIEF-DSM signs technology partnership agreement with Toyota Motorsport GmbH‍​

* SIGNS TECHNOLOGY PARTNERSHIP AGREEMENT WITH TOYOTA MOTORSPORT GMBH‍​

07 Nov 2017

UPDATE 1-Dutch firm DSM reports better-than-expected rise in Q3 profit

AMSTERDAM, Nov 2 Dutch speciality chemicals company DSM on Thursday said higher sales and tighter cost controls helped third-quarter core profit rise 13 percent, to 365 million euros ($425.3 million).

02 Nov 2017

Dutch firm DSM reports better-than-expected rise in Q3 profit

AMSTERDAM, Nov 2 Dutch speciality chemicals company DSM on Thursday said higher sales and tighter cost controls helped third-quarter core profit rise 13 percent, to 365 million euros ($425.3 million).

02 Nov 2017

BRIEF-Amyris Inc enters into agreement with Koninklijke DSM N.V.

* Amyris enters into product development and production agreement with Royal DSM for human nutrition ingredient

05 Oct 2017

French and Benelux stocks-Factors to watch on Sept 29

Sept 29 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

29 Sep 2017

BRIEF-Amyris enters into second major product development with Royal DSM

* Amyris Inc enters into second major product development and production agreement with Royal DSM

26 Sep 2017

BRIEF-Amyris says second tranche of $50 mln in a private placement days is being led by a $25-mln investment from Koninklijke​

* Amyris announces agreements for $50 million in second tranche of equity financing, exceeding previous target of $95 million

03 Aug 2017

UPDATE 2-DSM raises 2017 profit forecasts, shares jump

AMSTERDAM, Aug 1 Dutch speciality chemicals company DSM raised its profit forecast for 2017 on Tuesday after higher sales and tighter cost controls helped it report a better than expected 15 percent rise in second-quarter earnings.

01 Aug 2017

BRIEF-Aerie Pharmaceuticals enters into collaboration agreement with DSM

* Aerie Pharmaceuticals enters into collaboration agreement with DSM focused on technology to potentially deliver Aerie compounds to treat retinal diseases such as wet AMD

31 Jul 2017

Earnings vs. Estimates